DeFilipp, Z, Ancheta, R, Liu, Y, Hu, ZH, Gale, RP, Snyder, D, Schouten, HC, Kalaycio, M, Hildebrandt, GC, Ustun, C, Daly, A, Ganguly, S, Inamoto, Y, Litzow, M, Szer, J, Savoie, ML, Hossain, N, Kharfan-Dabaja, MA, Hamadani, M, Reshef, R, Bajel, A, Schultz, KR, Gadalla, S, Gerds, A, Liesveld, J, Juckett, MB, Kamble, R, Hashmi, S
, Abdel-Azim, H, Solh, M, Bacher, U, Lazarus, H, Olsson, R, Cahn, JY, Grunwald, MR, Savani, BN, Yared, J, Rowe, JM, Cerny, J, Chaudhri, NA, Aljurf, M, Beitinjaneh, A, Seo, S, Nishihori, T, Hsu, JW, Ramanathan, M, Alyea, E, Popat, U, Sobecks, R & Saber, W 2020, '
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study',
Biology of Blood and Marrow Transplantation, vol. 26, no. 3, pp. 472-479.
https://doi.org/10.1016/j.bbmt.2019.10.017